Does Ozempic Cause Hair Loss? What the Evidence Shows

“Ozempic hair loss” is one of the most searched side effects of the GLP-1 era, and the anxiety behind the search is understandable. The reassuring part is that when you look at the trial data and the likely mechanism, hair loss on these drugs is real but usually indirect, modest, and temporary — not a sign the medication is damaging your body.

What the trials actually reported

Hair loss (medically, alopecia) does appear in the clinical trial safety data, but at rates lower than the internet volume might suggest.

• In the STEP obesity trials of semaglutide 2.4 mg (the Wegovy dose), hair loss was reported in roughly 3% of participants versus about 1% on placebo.
• In the SURMOUNT-1 trial of tirzepatide (Zepbound), alopecia was reported in around 5–6% of participants at higher doses versus roughly 1% on placebo, and it was more common in women.

So there is a genuine signal above placebo — but it’s a minority effect, and the gap over placebo is a few percentage points, not a majority experience. Ozempic’s diabetes labeling, where weight loss is smaller, lists hair loss less prominently.

The pattern across trials points to the same explanation: more hair shedding tracks with more rapid, larger weight loss — which is the tell for telogen effluvium rather than a direct drug effect.

Why it happens: telogen effluvium

The mechanism almost certainly isn’t the drug poisoning hair follicles. It’s telogen effluvium — a well-known, reversible shedding pattern triggered by physiological stress, including rapid or large weight loss and lower calorie intake.

Here’s the biology in brief. Hair follicles cycle between a growth phase (anagen) and a resting/shedding phase (telogen). A significant metabolic stressor can push an unusually large share of follicles into the resting phase at once. Those hairs then shed together a few months later — which is why the shedding often shows up after the fastest phase of weight loss, not during the first week. Crash diets, major illness, surgery, and childbirth cause the same thing. GLP-1s are simply a very effective way to lose weight quickly, so they can trigger the same response.

What tends to help

Because the driver is usually rapid weight loss and reduced intake rather than the drug directly, the practical levers are about supporting the body through the change:

• Prioritize protein. Under-eating protein is common on appetite-suppressing drugs and is bad for both hair and lean mass. Aim for adequate daily protein even when appetite is low.
• Don’t rush the loss. A slower titration and a less aggressive rate of weight loss give follicles less of a shock.
• Check the basics. Iron, ferritin, vitamin D, thyroid, and zinc are all worth reviewing with a clinician if shedding is significant — deficiencies that worsen with reduced intake can compound the effect.
• Expect recovery. Telogen effluvium is self-limiting. Once weight stabilizes and nutrition is adequate, the follicles cycle back and regrowth typically follows over several months.

If hair loss is patchy rather than diffuse, or comes with other symptoms, that points away from simple telogen effluvium and toward something worth a dermatologist’s or physician’s evaluation.

The takeaway

Does Ozempic cause hair loss? Indirectly, in a minority of people — and mostly as a downstream effect of losing weight quickly rather than a direct toxicity. The trial rates are modest, the mechanism is a known reversible one, and the shedding usually recovers once weight and nutrition stabilize. Eating enough protein and not chasing the fastest possible loss are the most useful things within your control. Persistent or unusual hair loss is worth raising with your prescriber.

Sources

• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021;384:989–1002
• Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022;387:205–216
• Telogen effluvium — overview, StatPearls / NCBI Bookshelf